Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CODX Co-Diagnostics, Inc. Common Stock
$1.16 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CODX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 8.1M
Enterprise value 5.4M
Trailing PE -0.032907800471529
Forward PE -1.3975904
PEG Ratio 0.00075457376877391
Enterprise to EBITDA -0.186
Enterprise to revenue 7.489
Price to book MRQ 0.44512662
Price to sales TTM 11.22607

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 721.4K
EBITDA -29090594
Diluted EPS TTM -25.89
Total Cash (MRQ) 3.6M
Current ratio (MRQ) 1.813
Operating Cash Flow (TTM) -27103204

CODX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CODX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.